In Vitro Services
Our in vitro services group can support late stage discovery and development phase projects using cell based assays and biochemical based methods. We are able to grow and maintain commercial cell lines in dedicated facilities to study aspects such as biopotency, toxicity, metabolism etc. Our current end point assays use ELISA or spectrophotometric technology. We have developed and validated commercial kits as well as more bespoke assays based on client requirements e.g. enzyme activity or absolute measurement of specific biochemicals (e.g. hormones). We have also carried out investigative studies and supported non-clinical and clinical studies.
- Biochemical assays e.g. enzyme assays, biomarkers, etc
- Cell based assays
- Metabolism based assays e.g. plasma protein binding, metabolic stability (microsomes, hepatocytes) etc.
- Radioactive assays
- GLP / GCP compliant assays
CED Life ScienceThe CED Life Science Conference will be attended by Masha Kononov, Senior Director Emerging Pharma US and Gail Frey, Senior Director Key Accounts US.
CED Life ScienceDates: 26th - 27th FebruaryLocation: Raleigh, NC
Drug Delivery & Formulation SummitThe DDF Summit 2019 will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
Drug Delivery & Formulation SummitDates: 11th - 13th MarchLocation: Berlin, Germany
BioEurope SpringBioEurope Spring will be attended by Dr. Nathalie Huther, Business Development Manager Europe.
BioEurope SpringDates: 25th - 27th MarchLocation: Vienna, Austria